<DOC>
	<DOCNO>NCT02198807</DOCNO>
	<brief_summary>The objective study explore role fosmidomycin piperaquine non-artemisinin-based combination therapy acute uncomplicated Plasmodium falciparum administer three day . Together , fosmidomycin piperaquine fulfil WHO criteria combination therapy meeting three key parameter different mode action different biochemical target exhibit independent blood schizonticidal activity . Like artemisinins , fosmidomycin fast-acting , excellent safety record active exist drug-resistant parasite . Piperaquine long half life protect fosmidomycin much short live molecule selection resistant parasite provide post-treatment prophylaxis .</brief_summary>
	<brief_title>Evaluation Fosmidomycin Piperaquine Treatment Acute Falciparum Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<criteria>Male female subject age 1 60 year inclusive Body weight 5kg 90kg inclusive Acute manifestation monoinfection Plasmodium falciparum determine either rapid diagnostic test adult microscopically confirm asexual parasitaemia 1,000 150,000/uL fever axillary temperature &gt; 37.5 degress C oral/rectal/tympanic temperature &gt; 38.0 degree C history fever previous 72 hour Compliance contraceptive measure throughout study period 63 day female child bear potential To eligible inclusion study , subject must NOT meet follow criterion : Signs severe/complicated malaria accord WHO criteria Pregnancy exclude negative serum human chorionic gonadotrophin ( hCG ) test Lactation Mixed Plasmodium infection Severe vomit three occasion previous 24 hour Severe diarrhoea four occasion previous 24 hour Concomitant disease mask assessment response include abnormal liver function test bilirubin &gt; 40 µmol/L , aspartate aminotransferase ( ASAT ) alanine aminotransferase ( ALAT ) level &gt; x 2 upper limit normal impaired renal function creatinine level &gt; x 2 upper limit normal haemoglobin level &lt; 7.5g/dl white cell count &gt; 12000/µL History cardiovascular disease include arrhythmia QTc interval ≥ 450msec , respiratory disease include active tuberculosis , hepatic disease include jaundice , renal failure , malignancy , neurological disorder include convulsion psychiatric disturbance History immunological disease include Hepatitis A , B C HIVAIDS Severe malnutrition History hypersensitivity adverse reaction fosmidomycin , piperaquine , artesunate mefloquine Treatment antimalarial antibacterial agent within previous 28 day</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>